Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S McCune

Showing results (81-90 of 174) with videos related to

Pageof 18
Sort By:
Clinical and Translational Science|September 11, 2022
Lipidomics of cyclophosphamide 4-hydroxylation in patients receiving post-transplant cyclophosphamideSandi L Navarro, Zihan Zheng, Timothy W Randolph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalizationJeannine S McCune, Meagan J Bemer, Jeffrey S Barrett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2013
Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomesAndrew R Rezvani, Jeannine S McCune, Barry E Storer, et al.
Scientia Pharmaceutica|October 12, 2010
Effects of Garlic on Cytochromes P450 2C9- and 3A4-Mediated Drug Metabolism in Human HepatocytesBeatrice E Ho, Danny D Shen, Jeannine S McCune, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patientsDavid H Salinger, David K Blough, Paolo Vicini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 3, 2004
Potential of chemotherapy-herb interactions in adult cancer patientsJeannine S McCune, Amy J Hatfield, Anne A R Blackburn, et al.
The Annals of Pharmacotherapy|February 24, 2001
Evaluation of outcomes in converting from intravenous ondansetron to oral granisetron: an observational studyJ S McCune, M D Oertel, D Pfeifer, et al.
Cancer Chemotherapy and Pharmacology|November 7, 2014
Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administrationJeannine S McCune, Paolo Vicini, David H Salinger, et al.
Frontiers in Pharmacology|April 6, 2023
Precision sirolimus dosing in children: The potential for model-informed dosing and novel drug monitoringGuofang Shen, Kao Tang Ying Moua, Kathryn Perkins, et al.
Journal of Comparative Effectiveness Research|July 8, 2017
A stakeholder-informed randomized, controlled comparative effectiveness study of an order prescribing intervention to improve colony stimulating factor use for cancer patients receiving myelosuppressive chemotherapy: the TrACER studyAasthaa Bansal, Sean D Sullivan, Dawn L Hershman, et al.
Pageof 18

Showing results (81-90 of 174) with videos related to

Sort By:
Pageof 18
Clinical and Translational Science|September 11, 2022
Lipidomics of cyclophosphamide 4-hydroxylation in patients receiving post-transplant cyclophosphamideSandi L Navarro, Zihan Zheng, Timothy W Randolph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalizationJeannine S McCune, Meagan J Bemer, Jeffrey S Barrett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2013
Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomesAndrew R Rezvani, Jeannine S McCune, Barry E Storer, et al.
Scientia Pharmaceutica|October 12, 2010
Effects of Garlic on Cytochromes P450 2C9- and 3A4-Mediated Drug Metabolism in Human HepatocytesBeatrice E Ho, Danny D Shen, Jeannine S McCune, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patientsDavid H Salinger, David K Blough, Paolo Vicini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 3, 2004
Potential of chemotherapy-herb interactions in adult cancer patientsJeannine S McCune, Amy J Hatfield, Anne A R Blackburn, et al.
The Annals of Pharmacotherapy|February 24, 2001
Evaluation of outcomes in converting from intravenous ondansetron to oral granisetron: an observational studyJ S McCune, M D Oertel, D Pfeifer, et al.
Cancer Chemotherapy and Pharmacology|November 7, 2014
Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administrationJeannine S McCune, Paolo Vicini, David H Salinger, et al.
Frontiers in Pharmacology|April 6, 2023
Precision sirolimus dosing in children: The potential for model-informed dosing and novel drug monitoringGuofang Shen, Kao Tang Ying Moua, Kathryn Perkins, et al.
Journal of Comparative Effectiveness Research|July 8, 2017
A stakeholder-informed randomized, controlled comparative effectiveness study of an order prescribing intervention to improve colony stimulating factor use for cancer patients receiving myelosuppressive chemotherapy: the TrACER studyAasthaa Bansal, Sean D Sullivan, Dawn L Hershman, et al.
Pageof 18